| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Xenon Pharmaceuticals (NASDAQ:XENE) is preparing to release its quarterly earnings on Monday, 2025-11-03. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Xenon Pharmaceuticals to report an earnings per share (EPS) of $-1.16.
Anticipation surrounds Xenon Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
The company's EPS missed by $0.07 in the last quarter, leading to a 5.51% increase in the share price on the following day.
Here's a look at Xenon Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.00 | -0.90 | -0.84 | -0.81 |
| EPS Actual | -1.07 | -0.83 | -0.84 | -0.81 |
| Price Change % | 6.00 | -17.00 | -3.00 | -3.00 |
Shares of Xenon Pharmaceuticals were trading at $42.67 as of October 30. Over the last 52-week period, shares are up 0.04%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Xenon Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: XENE
